January 21, 2022
Take 6: Phil Low, College of Science and several startup companies
What can you do in six minutes? Brew a cup of coffee, answer email, or catch up with one of Purdue’s innovators. Between the lab, the classroom, bringing new ideas to market, and home, Purdue Innovators are busy trying to make the most of their time. The Take 6 is an interview series featuring faculty, innovators, leaders and community partners.
Phil Low is the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry — Biochemistry in Purdue University’s Department of Chemistry. He also is an entrepreneur whose research forms the foundation of companies Endocyte, Eradivir, ErythroCure, MorphImmune, Novosteo, On Target Laboratories and Umoja Biopharma.
On November 29, the U.S. Food and Drug Administration granted approvalfor the use of On Target Laboratories’ fluorescence imaging technology to illuminate ovarian cancer cells during surgery.
Read Low’s Take 6 on the PRF blog, The Line.